We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc

Delisted

SPPI was delisted on the 31st of July, 2023.

165 hedge funds and large institutions have $733M invested in Spectrum Pharmaceuticals Inc in 2019 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 82 increasing their positions, 27 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

204% more repeat investments, than reductions

Existing positions increased: 82 | Existing positions reduced: 27

5% less funds holding

Funds holding: 173165 (-8)

17% less capital invested

Capital invested by funds: $881M → $733M (-$147M)

26% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 23

97% less call options, than puts

Call options by funds: $342K | Put options by funds: $13.6M

Holders
165
Holders Change
-8
Holders Change %
-4.62%
% of All Funds
3.58%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
82
Reduced
27
Closed
23
Calls
$342K
Puts
$13.6M
Net Calls
-$13.2M
Net Calls Change
-$12.3M
Name Holding Trade Value Shares
Change
Change in
Stake
PPA
51
Parametric Portfolio Associates
Washington
$1.26M +$227K +25,430 +21%
State of Wisconsin Investment Board
52
State of Wisconsin Investment Board
Wisconsin
$1.24M +$28.6K +3,200 +2%
Canada Life
53
Canada Life
Manitoba, Canada
$1.22M
New York State Teachers Retirement System (NYSTRS)
54
New York State Teachers Retirement System (NYSTRS)
New York
$1.19M
DekaBank Deutsche Girozentrale
55
DekaBank Deutsche Girozentrale
Germany
$1.17M +$1.12M +125,600 +1,365%
KCM
56
Kennedy Capital Management
Missouri
$1.08M -$12.2K -1,365 -1%
California Public Employees Retirement System
57
California Public Employees Retirement System
California
$1.08M +$25.2K +2,822 +2%
Citigroup
58
Citigroup
New York
$1.07M +$571K +63,871 +105%
Two Sigma Advisers
59
Two Sigma Advisers
New York
$1.07M +$337K +37,700 +44%
MSL
60
Mackay Shields LLC
New York
$1.06M +$759K +84,897 +219%
TCM
61
Tekla Capital Management
Massachusetts
$987K
New York State Common Retirement Fund
62
New York State Common Retirement Fund
New York
$982K +$114K +12,700 +13%
PI
63
PineBridge Investments
New York
$971K +$766K +85,608 +316%
Balyasny Asset Management
64
Balyasny Asset Management
Illinois
$909K +$482K +53,842 +104%
FI
65
Fosun International
China
$830K
CSS
66
Cubist Systematic Strategies
Connecticut
$828K -$26.7K -2,988 -3%
Comerica Bank
67
Comerica Bank
Texas
$783K -$45.5K -5,089 -5%
AIG
68
American International Group
New York
$715K +$56.1K +6,272 +8%
Thrivent Financial for Lutherans
69
Thrivent Financial for Lutherans
Minnesota
$713K +$46K +5,139 +7%
CS
70
Credit Suisse
Switzerland
$670K -$119K -13,348 -15%
LCM
71
Laurion Capital Management
New York
$652K +$677K +75,708 New
TPSF
72
Texas Permanent School Fund
Texas
$622K +$4.97K +556 +0.8%
State of Tennessee, Department of Treasury
73
State of Tennessee, Department of Treasury
Tennessee
$610K +$33.3K +3,725 +6%
Manulife (Manufacturers Life Insurance)
74
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$609K +$37.6K +4,200 +6%
ACM
75
AlphaCrest Capital Management
New York
$603K +$626K +70,000 New

SPPI Hedge Fund Activity: Q2 2019 in Review

165 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q2 2019, worth a combined $733M — down 17% from $881M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of SPPI and 17 opened new positions — a net loss of 6 holders — while 27 trimmed existing stakes and 82 added.

The largest buyer was Renaissance Technologies, adding an estimated $9.25M. The largest seller was Armistice Capital, exiting entirely with an estimated $20.6M sold.

  • 165 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q2 2019, down from 173 in Q1 2019.
  • Funds reported $733M of Spectrum Pharmaceuticals Inc stock for Q2 2019, down 17% quarter-over-quarter.
  • 17 funds opened new Spectrum Pharmaceuticals Inc positions in Q2 2019 and 23 closed out, a net change of -6 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q2 2019 was Renaissance Technologies, an estimated $9.25M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q2 2019 was Armistice Capital, an estimated $20.6M sold.

Based on aggregated 13F filings for Q2 2019.